WETS
LAB icon

Wealth Enhancement Trust Services’s Standard BioTools LAB Stock Holding History

Wealth Enhancement Trust Services’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145 Buy
+176
New +$166 ﹤0.01% 1386

Other funds holding LAB

MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Wealth Enhancement Trust Services's LAB Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Standard BioTools (LAB) in Q2 2026: 176 shares worth $145. The stake represents ﹤0.01% of the portfolio and ranks #1386 among its holdings.

14 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Wealth Enhancement Trust Services held 176 shares of Standard BioTools worth $145 as of Q2 2026.
  • Standard BioTools was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Standard BioTools made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1386 holding.
  • 14 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.